1. 1396. Predictions of Isavuconazonium Sulfate Dosage in Patients Aged 6 Months: <18 Years by Physiologically Based Pharmacokinetic Modeling. (26th November 2018) Authors: Desai, Amit; Kovanda, Laura; Lademacher, Christopher; Hope, William; Neely, Michael; Bonate, Peter; Edginton, Andrea Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2a, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral gonadotropin-releasing hormone antagonist, ASP1707, in postmenopausal female patients with rheumatoid arthritis taking methotrexate. Issue 1 (2nd January 2021) Authors: Takeuchi, Tsutomu; Tanaka, Yoshiya; Higashitani, Chieri; Iwai, Megumi; Komatsu, Kanji; Akazawa, Rio; Lademacher, Christopher Journal: Modern rheumatology Issue: Volume 31:Issue 1(2021) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis. Issue 10 (October 2018) Authors: Benjamin, Daniel K.; Kaufman, David A.; Hope, William W.; Smith, P. Brian; Arrieta, Antonio; Manzoni, Paolo; Kovanda, Laura L.; Lademacher, Christopher; Isaacson, Brigit; Jednachowski, Deborah; Wu, Chunzhang; Kaibara, Atsunori; Walsh, Thomas J. Journal: Pediatric infectious disease journal Issue: Volume 37:Issue 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients. (March 2021) Authors: Ljungman, Per; Bermudez, Arancha; Logan, Aaron C.; Kharfan-Dabaja, Mohamed A.; Chevallier, Patrice; Martino, Rodrigo; Wulf, Gerald; Selleslag, Dominik; Kakihana, Kazuhiko; Langston, Amelia; Lee, Dong-Gun; Solano, Carlos; Okamoto, Shinichiro; Smith, Larry R.; Boeckh, Michael; Wingard, John R.; Cyw... Journal: EClinicalMedicine Issue: Volume 33(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A randomized, phase 2 study of ASP0113, a DNA‐based vaccine, for the prevention of CMV in CMV‐seronegative kidney transplant recipients receiving a kidney from a CMV‐seropositive donor. Issue 12 (20th June 2018) Authors: Vincenti, Flavio; Budde, Klemens; Merville, Pierre; Shihab, Fuad; Ram Peddi, V.; Shah, Malay; Wyburn, Kate; Cassuto‐Viguier, Elisabeth; Weidemann, Alexander; Lee, Misun; Flegel, Teresa; Erdman, Jay; Wang, Xuegong; Lademacher, Christopher Journal: American journal of transplantation Issue: Volume 18:Issue 12(2018) Page Start: 2945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA). Issue 12 (December 2020) Authors: Santoro, Nanette; Waldbaum, Arthur; Lederman, Samuel; Kroll, Robin; Fraser, Graeme L.; Lademacher, Christopher; Skillern, Laurence; Young, James; Ramael, Steven Journal: Menopause Issue: Volume 27:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: An open‐label, phase 3, dose‐titration study. Issue 6 (31st May 2021) Authors: Baka‐Ostrowska, Małgorzata; Bolong, David T.; Persu, Cristian; Tøndel, Camilla; Steup, Achim; Lademacher, Christopher; Martin, Nancy Journal: Neurourology and urodynamics Issue: Volume 40:Issue 6(2021) Page Start: 1490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population. (September 2017) Authors: Delgado-Herrera, Leticia; Lasch, Kathryn; Zeiher, Bernhardt; Lembo, Anthony J.; Drossman, Douglas A.; Banderas, Benjamin; Rosa, Kathleen; Lademacher, Christopher; Arbuckle, Rob Journal: Therapeutic advances in gastroenterology Issue: Volume 10:Number 9(2017) Page Start: 673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Fezolinetant in the treatment of vasomotor symptoms associated with menopause. (3rd July 2021) Authors: Depypere, Herman; Lademacher, Christopher; Siddiqui, Emad; Fraser, Graeme L Journal: Expert opinion on investigational drugs Issue: Volume 30:Number 7(2021) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial. (29th November 2017) Authors: Kontoyiannis, Dimitrios P; Selleslag, Dominik; Mullane, Kathleen; Cornely, Oliver A; Hope, William; Lortholary, Olivier; Croos-Dabrera, Rodney; Lademacher, Christopher; Engelhardt, Marc; Patterson, Thomas F Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 3(2018) Page Start: 757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗